Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...

"My new year resolution is to be PETTY," tweeted rapper Ja Rule, in the lead-up to New Year's Eve last year. "A gentle ...